20,188 Shares in Monro, Inc. (NASDAQ:MNRO) Bought by PharVision Advisers LLC

PharVision Advisers LLC purchased a new stake in shares of Monro, Inc. (NASDAQ:MNRO - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 20,188 shares of the auto parts company's stock, valued at approximately $501,000. PharVision Advisers LLC owned 0.07% of Monro as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also bought and sold shares of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Monro by 9.2% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 65,004 shares of the auto parts company's stock valued at $1,612,000 after acquiring an additional 5,471 shares in the last quarter. Squarepoint Ops LLC bought a new stake in Monro during the fourth quarter worth approximately $2,866,000. Sherbrooke Park Advisers LLC bought a new position in shares of Monro during the fourth quarter valued at approximately $353,000. ProShare Advisors LLC bought a new position in shares of Monro during the fourth quarter valued at approximately $223,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Monro by 3.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,995 shares of the auto parts company's stock valued at $421,000 after buying an additional 577 shares during the last quarter.

Monro Price Performance

Shares of Monro stock opened at $13.72 on Wednesday. Monro, Inc. has a twelve month low of $12.20 and a twelve month high of $31.49. The business has a 50-day moving average price of $14.65 and a 200 day moving average price of $20.24. The company has a quick ratio of 0.19, a current ratio of 0.54 and a debt-to-equity ratio of 0.45. The firm has a market cap of $410.90 million, a PE ratio of 21.44, a P/E/G ratio of 2.05 and a beta of 0.95.

Analyst Ratings Changes

Several analysts have issued reports on MNRO shares. Wells Fargo & Company dropped their target price on Monro from $20.00 to $15.00 and set an "equal weight" rating on the stock in a research report on Monday, April 28th. Wedbush lowered their price objective on Monro from $27.00 to $19.00 and set an "outperform" rating for the company in a research report on Tuesday, April 1st. Finally, Stephens raised Monro from an "equal weight" rating to an "overweight" rating and lowered their price objective for the stock from $21.00 to $18.00 in a research report on Friday, April 4th.

About Monro

Monro, Inc provides automotive undercar repair, and tire sales and services in the United States. It offers replacement tires and tire related services, automotive undercar repair services, and routine maintenance services primarily to passenger cars, light trucks, and vans. The company also provides other products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment.

Want to see what other hedge funds are holding MNRO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monro, Inc. (NASDAQ:MNRO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.